Background: Endothelin (ET) is an endothelium-derived multifunctional peptide that produces a potent, long-lasting vasoconstriction. Nitric oxide (NO), besides being the most important endotheliumderived relaxant factor in blood vessels, is supposed to be involved in regulating the interactions among endothelium, adhesive molecules, and leukocytes.
Blood vascular endothelium releases vasoactive mediators that originally were called endothelium-derived relaxing factors (EDRF) and endothelium-derived contracting factors (EDCF) according to their action on the muscular wall. Subsequent studies have provided convincing evidence that endothelin (ET) and nitric oxide (NO) are responsible for most of the contracting activity and relaxing activity, respectively, by the regulation of vascular smooth muscle cells via paracrine mechanism (Palmer et al., 1987; Yanagisawa et al., 1988; Vane et al., 1990; Moncada et al., 1991; Masaki et al., 1992; Moncada, 1992; Moncada and Higgs, 1993) .
ET is a 21-amino-acid peptide that, besides being the most potent and long-acting vasoconstrictive peptide so far discovered, is able to exert several biological actions, including neuromodulation, stimulation of cell growth, and modulation of hormone release (Yanagisawa et al., 1988; Rubanyi and Parker Botelho, 1991; Masaki et al., 1992) . NO is a free radical gas produced intracellularly through the conversion of L-arginine to L-citrulline by the enzyme NO synthase (NOs). There is now evidence for multiple forms of this enzyme, all of which require Nicotinamide Adenine Dinucleotide Phosphate Reduced (NADPH) as a cofactor (Moncada et al., 1991; Forstermann et al., 1991) . One group of enzymes is constitutive and requires calcium and calmodulin as cofactors. The other group is inducible in response to cytokines or endotoxin and is calcium/calmodulin independent. Both constitutive and inducible isoforms occur in vascular endothelium (Moncada et al., 1991; Moncada, 1992) . Under basal conditions, NO is supposed to be the most important regulator of vascular tone, and it is essential for maintaining normal vascular resistance (Ignarro et al., 1987; Palmer et al., 1987; Moncada and Higgs, 1993) . Indeed, the inactivation of NOs causes vasoconstriction and long-lasting pressor response (Moncada et al., 1991; Berdeaux, 1993) . Increasing evidence now exists that NO may exert other biological actions such as inhibition of platelet aggregation, attenuation of leukocytes and endothelium interaction, and maintenance of the vascular permeability barrier (Ignarro, 1989; Kubes and Granger, 1992) .
Lymph propulsion and return from the tissues are carried out by both passive and active driving mechanisms. The passive mechanism is caused by compression and suction of lymphatic vessels, resulting from extrinsic activities of the surrounding tissue. The passive driving system is probably the main mechanism of propulsion of the lymph in the initial lymphatics and in those collecting vessels with a thin smooth muscle layer. The active driving mechanism is due to intrinsic contractility of lymphatic vessels, promoted by the activity of the smooth muscle cells of the lymphatic wall (Ohhashi et al., 1980; Drake et al., 1985; Ohhashi, 1993) . The existence of the active mechanism promoting the lymph flow induces the belief that local mediators could modulate smooth muscle cell tone and contractility in lymphatic vessels. Previous investigations have suggested that some vasoactive substances may modulate the contractility of the lymphatic vessel wall (Dabney et al., 1988 Fortes et al., 1989; Ferguson and DeFilippi, 1994) . Other studies have demonstrated that lymphatic endothelial cells are able to release vasodilator agents. These findings suggested the hypothesis that lymphatic vessels may regulate their own vascular tone (Ohhashi and Takahashi, 1991; Bohlen and Lash, 1992; Ohhashi and Yokoyama, 1994) .
Although ET-like immunoreactivity has been demonstrated in the lymphatic vessel wall, some discrepancies exist as to whether ET is localized only in the endothelial layer or also in the muscular layer (Ohkuma, 1991) .
In the present study, we investigated the presence of ET and constituive NOs in lymphatic vessels and in cultured endothelial cells by immunocytochemical reactions.
MATERIALS AND METHODS

Collection of Lymphatic Vessels and Culture of Lymphatic Endothelial Cells
Lymphatic vessels (n 5 18) were obtained from 10 bovine mesenteries from 2-3-year-old animals. The lymphatic vessel network was delineated by injecting a solution of 0.1% Evan's blue in phosphate buffered saline (PBS) into mesenteric lymph nodes. Some vessels (n 5 10) were cut into small pieces and immediately fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.3, at room temperature for 3 hr. The specimens were washed in 0.05 M Tris buffer, pH 7.4, containing 0.1 M NaCl (0.15 M Tris buffered saline; TBS) and 15% sucrose overnight, embedded in Tissue Tek II OCT (Miles, Naperville, IL), rapidly frozen in isopentane cooled by liquid nitrogen, and cut in a cryostat.
Endothelial cells for cultures were obtained by collagenase digestion from other isolated lymphatic vessels (n 5 8). Dye-filled vessels were cannulated at both ends and washed with normal saline solution and incubated at 37°C for 10 min. The vessels were then drained with culture medium TC 199 containing Earle's salts and L-glutamine and supplemented with 20% fetal calf serum, NaHCO 3 2.2 mg/ml, penicillin 200 U/ml, and streptomycin 200 mg/ml. After washing, the vessels were incubated with 0.2% collagenase in saline solution at 37°C for 5 min. The fluid was collected and placed in Costar well plates containing coverslips for cell cultures. Cells were grown at 37°C in a humidified incubator with air and 5% CO 2 . The cells were fixed for 5 min in 4% paraformaldehyde in 0.1 M phosphate buffer and washed in TBS before immunostaining.
Light Microscopy Immunocytochemistry
Sections of lymphatic vessels (at least 5/vessel; N 5 50) and primary cultures (n 5 8) of lymphatic vessel cells were trated for the immunocytochemical reaction to detect ET and endothelial constitutive NOs by indirect immunofluorescence and immunoperoxidase (Polak and Van Noorden, 1986) . The demonstraction of the endothelial nature of cultured cells was also performed by the immunolocalization of the von Willebrand factor (vWf).
All the samples were treated with 0.3% Triton X 100 in TBS for 1 min and rinsed in TBS thoroughly. Samples for immunoperoxidase reaction were also incubated with 0.3% hydrogen peroxide in TBS for 30 min to remove endogenous peroxidase activity. Normal goat serum, diluted to 1:20 in TBS, was applied for 30 min at room temperature to reduce possible background staining. The samples were then incubated overnight at 4°C with rabbit polyclonal antisera to ET, NOs, and von Willebrand protein (dilutions between 1:50 and 1:1,000). The samples were washed in TBS, incubated with either tetramethylrhodamine isothiocyanate (TRITC), conjugated or biotinylated goat anti-rabbit IgG, diluted to 1:100 in TBS for 30 min, and then washed in TBS.
The samples were stained with TRITC antibodies and mounted with TBS glycerol (1:1). The samples labeled with biotinylated antibodies were incubated with streptavidin-biotinylated peroxidase complexes diluted to 1:200 in TBS for 1 hr at room temperature. The samples were washed in TBS, and peroxidase was visualized by incubation with 0.03% 3,38-diaminobenzidine tetrahydrochloride (DAB) solution in 0.05 M TrisHCl, pH 7.4, to which 0.02% hydrogen peroxide was added before use.
Some sections and cell monolayers were lighly counterstained with haematoxylin and mounted in DPX for light microscope examinations.
Conventional Electron Microscopy and Electron Microscopy Immunocytochemistry
Cultures (n 5 8) of lymphatic vessel cells were routinely processed for electron microscopy to assess the endothelial nature of cultured cells. Briefly, cell culture monolayers were fixed with 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, for 30 min at 37°C and for 30 min at 4°C. The monolayers were postfixed in 1% OsO 4 in 0.2 M collidine buffer, pH 7.4, for 1 hr at 4°C, dehydrated, and embedded in epoxy resin. Ultrathin sections (80 nm) were cut perpendicularly to the monolayer plane and countrasted with uranyl acetate and lead citrate for transmission electron microscope observations. Small pieces of lymph vessels (n 5 8) were fixed in 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.3, at room temperature for 6 hr. After washing in 0.05 M Tris buffer, pH 7.4, containing 0.1 M NaCl (TBS), the samples were processed for the immunocytochemical identification of ET and NOs immunoreactivities by using a preembedding immunoperoxidase technique, as described previously (Sexton et al., 1995) . The samples were processed according to the protocol described for the localization of ET and NOs immunoreactivities at light microscopy. After peroxidase visualization with the DAB solution, the samples of lymphatic vessels were fixed in 2.5% glutaraldehyde, postfixed in 1% OsO 4 , and routinely embedded in epoxy resin. Immunostained lymphatic vessels were cut transversally to obtain semithin and ultrathin sections. At least three sections per lymphatic vessel were observed.
Antisera and Specificity Controls of the Immunocytochemical Reactions
The antisera against synthetic ET-1 and endothelial constitutive NOs were raised in rabbits and have been characterized elsewhere (Yoshizawa et al., 1990; Casasco et al., 1991 Casasco et al., , 1993 Springall et al., 1991 Springall et al., , 1992 Buttery et al., 1994) . Pertinent specificity tests were performed, including adsorption of the specific antisera with related and unrelated antigens, omission of the first layer, and substitution of an inappropriate antiserum or a nonimmune serum for the specific primary antisera (Polak and Van Noorden, 1986) .
As for ET antiserum, immunostaining was prevented by adsorption of antiserum with synthetic ET-1, -2, or -3 (10 nmol in 1 ml antiserum diluted 1:700 in TBS), indicating that the antiserum cross reacts with different ET isoforms.
NOs antiserum was raised against a synthetic 15-residue peptide, based on deduced amino acid sequences of cDNA encoding the bovine and human endothelial constitutive NOs Marsden et al., 1992) . The peptide sequence was VTSRIRTQSFSLQER-C, corresponding to amino acids 1172-1186 of the deduced amino acid sequence, with a cysteine residue at the C terminus to assist coupling to carrier. This sequence represents a one that is identical between the bovine and human endothelial NOs Marsden et al., 1992) and has low homology with other isoforms of NOs (,50% with rat brain NOs and virtually no homology with macrophage NOs). The peptide was coupled to maleimide-activated key-hole limpet hemocyanin and used to immunize rabbits.
The antiserum to human von Willebrand protein and the secondary antibodies were purchased from Dakopatts (Glostrup, Denmark). Biotinylated probes were purchased from Amersham International (Amersham, England).
RESULTS Immunocytochemistry
ET and NOs immunoreactivities were detectable within endothelial cells of the isolated lymphatic vessels at both light and electron microscopic levels (Figs. 1a & 1b and 2a & 2b) . The immunostaining was continuous along the endothelial layer. We saw no specific immunostaining in the muscular or adventitial layers with ET or NOs antisera in any of the sections examined.
In addition, lymphatic vessel endothelial cells in culture were immunoreactive with ET and NOs antisera ( Fig. 3a & 3b) . The immunostaining, although diffuse throughout the cytoplasm, appeared more intense in the perinuclear portion of the cytoplasm. Cultured cells were also positive for the demonstraction of vWf. The reaction showed a granular pattern within the cytoplasm (not shown).
In control samples that were not incubated with primary antisera, no immunostaining could be observed (Fig. 3c) .
Electron Microscopy
At the ultrastructural level, lymphatic endothelial cells exibited a flattened shape with a subtle profile (Fig. 4a) . The cells were joined to one another by overlappings or interdigitations of the cellular edges. The cytoplasm, particularly in the perinuclear regions (Fig. 4b) , contained rough endoplasmic reticulum cisternae, ribosomes, mitochondria, filaments, vacuoles, and vesicles. Moreover, it usually presented Weibel-Palade bodies, the cytoplasmic organelles characteristic of endothelial cells.
DISCUSSION
The present study demonstrates the occurrence and distribution of ET and constitutive NOs immunoreactivities in the endothelium of lymphatic vessels. Because ET and NOs immunoreactivities were observed in lymphatic endothelium both in vivo and in vitro, we propose that cultured lymphatic endothelial cells may be profitably employed in further studies to investigate the role of lymphatic endothelium in the generation of vasoactive molecules.
To date, the exact localization of ET in lymphatic vessel walls has not been completely satisfactory (Okhuma, 1991) . Our data confirm the occurrence of ET in the lymphatic vascular wall and provide evidence that this peptide is produced exclusively by the endothelial cell layer. Lymphatic endothelial cells maintain their positivity to ET reaction when removed from the vascular wall and cultured, as it has been demonstrated for blood vessel endothelium (Nakamura et al., 1990; Loesch et al., 1991) . Our data are at variance with those reported by Ohkuma (1991) who also found ET immunoreactivity in the muscular layer of lymphatic and blood vessels. Indeed, ET immunoreactivity has been revealed by using immunocytochemistry in different cell types (e.g., neurons, epithelial cells, macrophages), and the possible production of ET by smooth muscle cells in vitro has been reported (Resink et al., 1990) . However, according to previous morphological studies, we never found ET immunoreactivity or mRNA in smooth muscle cells of any organ in vivo (MacCumber et al., 1989; Casasco et al., 1991 Casasco et al., , 1993 Giaid et al., 1991a,b; Springall et al., 1991) .
Previous physiological studies have shown that lymphatic vessels constrict in response to exogenous ET, thus suggesting that this peptide may contribute to the control of lymph flow by affecting lymphatic vessels contractility . The occurrence of ET immunoreactivity within lymphatic endothelial cells supports the view that lymphatic vessels may modulate with a self-mechanism for their own contractility, thus promoting the active driving mechanism for lymph flow (Ohhashi, 1993) .
The detection of constitutive NOs immunoreactivity in lymphatic vessel endothelial cells in situ and in cultured endothelial cells isolated from lymphatic vessels strongly suggests that these cells are able to produce NO. Previous studies have suggested that this molecule might play a pivotal role in the molecular mechanisms that regulate lymphatic vessel tone and lymph flow (Ohhashi and Takahashi, 1991; Ohhashi and Yokoyama, 1994) . The antiserum used in our experiments to reveal NOs was raised against the endothelial constitutive isoform of the enzyme. Indeed, we found specific immunostaining only within lymphatic endothelial cells, whereas the muscular and adventitial layers were negative to the reaction. Nevertheless, the inducible form of NOs has been localized in smooth muscle cells (for a review, see Moncada, 1992) . Therefore, the possibility that smooth muscle cells of the lymphatic vessels are also able to produce the inducible isoform of NOs cannot be excluded.
A relationship between NO synthesis and changes in vascular permeability has been observed in blood vessels (Kubes and Granger, 1992) . It has been also observed that the inactivation of NO by superoxide may be an important event at the onset of inflammation when leukocyte extravasation occurs (Ohhashi and Yokoyama, 1994). Moreover, a correlation in vivo between decreased NO synthesis and expression of Pselectin, an adhesive molecule mediating the adhesion of platelets and neuthrophyls to blood endothelium, has been described (Davenpeck et al., 1994) . Because Pselectin has been shown to occur in lymphatic endothelium (Marchetti et al., 1995; Di Nucci et al., 1996) , it may be tentatively hypothesized that NO production by endothelial NOs may also influence P-selectin activity in lymphatic vessels. This aspect might be important in the mechanisms that regulate the leukocyte adhesion to endothelial cells and extravasation.
Taken together, our immunocytochemical findings suggest the existence in lymphatic endothelial cells of both vasoconstrictor and vasodilator factors, namely ET and NO, respectively, that may be involved in the regulation of contractile activity of the vessel. Through these and probably other factors, the lymphatic vessels have the possibility to not only control the vascular tone but also produce and regulate the contractile activity necessary to promote the lymph flow according to the active driving mechanism. In line with this view, muscular tone has been shown to play an important role in the regulation of spontaneous contractions in lymphatic vessels (Ferguson and DeFilippi, 1994; Ohhashi and Yokoyama, 1994) . However, because significant differences exist among the vessels of different organs with regard to the thickness of the muscular layer of the vascular wall, it is reasonable to presume that different vessels may have different capacities to respond to vasoactive factors.
